Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,234,400 | 2,090,400 | 1,859,464 | 1,351,128 | 1,102,172 |
| Marketable Securities | 2,452,600 | 1,809,900 | 788,690 | 1,250,173 | 1,894,580 |
| Receivables | 1,061,400 | 960,500 | 945,531 | 706,429 | 438,617 |
| Inventories | 340,400 | 259,500 | 189,573 | 260,130 | 100,683 |
| Income taxes - deferred | 25,300 | 93,200 | 116,751 | 151,779 | 49,817 |
| Other current assets | 436,400 | 320,200 | 453,216 | 623,560 | 258,935 |
| TOTAL | $7,550,500 | $5,533,700 | $4,353,225 | $4,343,199 | $3,844,804 |
| Non-Current Assets | |||||
| PPE Net | 593,400 | 578,400 | 506,042 | 509,919 | 297,792 |
| Investments And Advances | 0 | 0 | 0 | 23,073 | 21,476 |
| Intangibles | 4,880,900 | 5,143,200 | 4,731,918 | 5,144,842 | 927,658 |
| Other Non-Current Assets | 353,400 | 479,000 | 414,725 | 156,129 | 297,581 |
| TOTAL | $5,827,700 | $6,200,600 | $5,652,685 | $5,833,963 | $1,544,507 |
| Total Assets | $13,378,200 | $11,734,300 | $10,005,910 | $10,177,160 | $5,389,311 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 544,800 | 308,500 | 526,684 | 0 | N/A |
| Accounts payable and accrued liabilities | 156,200 | 145,600 | 121,525 | 94,465 | 36,629 |
| Accrued Expenses | 1,001,100 | 775,700 | 701,707 | 592,336 | 315,608 |
| Other current liabilities | 199,700 | 431,300 | 138,424 | 309,214 | 93,767 |
| TOTAL | $1,945,500 | $1,690,200 | $1,539,972 | $1,070,382 | $494,705 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,196,500 | 2,771,300 | 1,275,585 | 1,247,584 | N/A |
| Deferred Revenues | 27,700 | 17,300 | 14,346 | 16,362 | 1,827 |
| Other Non-Current Liabilities | 817,700 | 543,700 | 890,681 | 968,389 | 493,473 |
| TOTAL | $5,842,800 | $4,349,600 | $2,953,211 | $3,111,308 | $500,000 |
| Total Liabilities | $7,788,300 | $6,039,800 | $4,493,183 | $4,181,690 | $994,705 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 812,040 | 837,489 | 877,621 | 929,798 | 919,462 |
| Common Shares | 9,100 | 5,000 | 4,874 | 4,822 | 4,676 |
| Retained earnings | 4,472,500 | 3,022,600 | 1,566,416 | 248,266 | -632,246 |
| Other shareholders' equity | 93,900 | -49,900 | -62,042 | -61,856 | -88,946 |
| TOTAL | $5,589,900 | $5,694,500 | $5,512,727 | $5,995,472 | $4,394,606 |
| Total Liabilities And Equity | $13,378,200 | $11,734,300 | $10,005,910 | $10,177,162 | $5,389,311 |